1. 1. Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, et al. A living biobank of breast cancer organoids captures disease heterogeneity. AlternCellate Cell. 2018; 172(1-2):373-86. e10.
2. 2. Zahmatkesh B, Keramat A, Alavi N, Khosravi A, Kousha A, Motlagh AG, et al. Breast cancer trend in Iran from 2000 to 2009 and prediction till 2020 using a trend analysis method. AlternAsian Pacific Journal of Cancer Preventionate Asian Pacific Journal of Cancer Prevention. 2016; 17(3):1493-8.
3. 3. Keyhanian s, Jannat alipoor z, Lohrasbi e, Fotoukian z, Saravi mm. Evaluation of Biologic Markers Frequency and Their Correlation with Some Determinant Prognostic Factors in Women with Breast Cancer Referred to Oncology Clinic of Imam Sajjad Hospital of Ramsar during 2002-2012. Alternscientific journal of ilam university of medical sciencesate scientific journal of ilam university of medical sciences. 2015; 22(7):115-28.
4. 4. Moghni M, Mokhtariyan K. Correlations of estrogen or progesterone receptors with grade of invasive ductal carcinomas of the breast in women referred to pathology center in Chaharmahal va Bakhtiari province Iran. AlternJournal of Shahrekord University of Medical Sciencesate Journal of Shahrekord University of Medical Sciences. 2009; 11(3):40-5.
5. 5. Shahidsales S, Hosseini S, Ahmadi-Simab S, Ghavam-Nasiri M. The importance of Prognostic factors (ER, PR, P53) in breast cancer and their relationship with stage of disease. Alternmedical journal of mashhad university of medical sciencesate medical journal of mashhad university of medical sciences. 2014; 57(2):457-63.